Studies about Copeptin

Can copeptin emerge from the growing shadow of the troponins?

This editorial refers to ‘Early discharge using single cardiac troponin and copeptin testing in patients with suspected acute coronary syndrome (ACS): a randomized, controlled clinical process study.’, by M. Möckel et al.
https://www.ncbi.nlm.nih.gov/pubmed/24847154 >

Additional Info

  • Indication: Cardiology
  • Authors: Gandhi PU and Januzzi JL, Jr.
  • Source: Eur Heart J 2015;36 (6),Feb 7: 333-6.
  • Access: Open Access

Early discharge using single cardiac troponin and copeptin testing in patients with suspected acute coronary syndrome (ACS): a randomized, controlled clinical process study

After clinical work-up and single combined testing of troponin and copeptin to rule-out AMI, early discharge of low- to intermediate risk patients with suspected ACS seems to be safe and has the potential to shorten length of stay in the ED.
https://www.ncbi.nlm.nih.gov/pubmed/24786301 >

Additional Info

  • Indication: Cardiology
  • Authors: Mockel M, Searle J, Hamm C, Slagman A, Blankenberg S, Huber K, Katus H, Liebetrau C, Muller C, Muller R, Peitsmeyer P, von Recum J, Tajsic M, Vollert JO and Giannitsis E
  • Source: Eur Heart J 2015;36 (6),Feb 7: 369-76.
  • Access: Open Access
Page 5 of 5

thermo scientific applied biosystems invitrogen fisher scientific unity lab service